PATENT CLAIM ANALYSIS

Application Number: 15872750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "144100"]

Abstract:
The present invention relates to an attenuated mutant strain of  Salmonella  comprising a recombinant DNA molecule encoding Wilms' tumor Protein I. In particular, the present invention relates to the use of said attenuated mutant strain of  Salmonella  in cancer immunotherapy.

Claim (Index 21):
The method of  claim 13 , wherein the solid tumor is selected from lung cancer, breast cancer, esophageal, colon, colorectal, gastric, cholangioductal, pancreatic cancer, glioblastoma, head and neck cancer, synovial sarcoma, angiosarcoma, osteosarcoma, thyroid cancer, cervical, endometrial, ovarian cancer, neuroblastoma, rhabdomyosarcoma and prostate cancer.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 86.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15785743', '14409434', '14366186', '14888831', '11840928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6053411239681902
- 35 USC 102 Novelty (BERT): 0.5466349948729856
- Combined Prediction Score: 0.5994705110586697
- Mean Citation Score: 313.98233
- Max Citation Score: 411.2976
- Similarity Product: 292.0578884387969

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test